References
Koch R: Die aetiologie des tuberculose. Mitt Kaiser Gesundh 2:1, 1884
Evans AS: Causation and disease: The Henle-Koch postulates revisited. Yale J Biol Med 49:175–195, 1976
Hill AB: The environment and disease: Association or causation. Proc R Soc Med 58:295–300, 1965
Marshall BJ, McGechie DB, Rogers PA, Glancy RJ: PyloricCampylobacter infection and gastroduodenal disease. Med J Austr 142:439–444, 1985
Coghlan JG, Gilligan D, Humphries H, McKenna D, Dooley C, Sweeney E, Keane C, O'Morain C:Campylobacter pylori and recurrence of duodenal ulcers—a 12-month follow-up study. Lancet 2:1109–1111, 1987
Rauws EAJ, Langenberg W, Houthoff HJ, Zanen HC, Tytgat GNJ:Campylobacter pyloridis-associated chronic active antral gastritis; a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology 94:33–40, 1988
Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackbourn S, Phillips M: Prevention of nitroimidazole resistance inCampylobacter pylori by co-administration of colloidal bismuth subcitrate: Clinical andin vitro studies. J Clin Pathol 41:207–210, 1988
Lamouliatte H, Mégraud F, DeMascarel A, Roux D, Quinton A:Campylobacter pyloridis and epigastric pain: Endoscopic, histological and bacteriological correlations. Gastroenterol Clin Biol 11:212–216, 1987
Bateson EM: Duodenal ulcer—does it exist in Australian Aborigines? Aust NZ J Med 6:545–547, 1976
Dwyer B, Nanxiong S, Kaldor J, Wee T, Lambert J, Luppino M, Flannery G: Antibody response toCampylobacter pylori in an ethnic group lacking peptic ulceration. Scand J Infect Dis 20:63–68, 1988
Mégraud F, Brassens-Rabbé MP, Denis F, Belbouri A, Hoa DQ: Seroepidemiology ofCampylobacter pylori in various populations. J Clin Microbiol 27:1870–1873, 1989
Sipponen P, Varis K, Fraki O, Korri UM, Seppala K, Siurala M: Cumulative 10 year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis. Scand J Gastroenterol 25:966–973, 1990
Queiroz DMM, Quintao JGA, Rocha GA, Barbosa AJA, Mendes EN:Helicobacter pylori density on antral mucosa of patients with and without duodenal ulceration. Gastroenterol Clin Biol 15:558, 1991
Weber J, Asteimer W, Riemann JF: Higher density of colonisation byCampylobacter pylori in patients with duodenal ulcer.In Gastroduodenal Pathology andCampylobacter pylori. F Mégraud, H Lamouliatte (eds). Amsterdam, Elsevier, 1989, pp 277–280
Lingwood CA, Law H, Pellizari A, Sherman P, Drumm B: Gastric glycerolipid as a receptor forCampylobacter pylori. Lancet 1:238–241, 1989
Wyatt JI, Rathbone GJ, Dixon MF, Heatley RV:Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J Clin Pathol 40:841–848, 1987
McColl KEL, Fullarton GM, Nujumi AM, McDonald AM, Brown IL, Hilditch TE: Lowered gastrin and gastric acidity after eradication ofCampylobacter pylori in duodenal ulcer. Lancet 2:499–500, 1989
Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J:Campylobacter pylori and duodenal ulcers: The gastrin link. Lancet 1:1167–1168, 1989
Leunk RD, Johnson PT, David BC, Kraft WG, Morgan DR: Cytotoxic activity in broth culture filtrates ofCampylobacter pylori. J Med Microbiol 26:93–99, 1988
Smoot DT, Mobley HLT, Chippendale GR, Lewison JF, Resau JH:Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun 58:1992–1994, 1990
Xu JK, Goodwin CS, Cooper M, Robinson J: Intracellular vacuolization caused by the urease ofHelicobacter pylori. J Infect Dis 161:1302–1304, 1990
Mai UEH, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD: Soluble surface proteins fromHelicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 87:894–900, 1991
Tytgat GNJ, Axon ATR, Dixon MF, Graham DY, Lee A, Marshall BJ:Helicobacter pylori: Causal agent in peptic ulcer disease?In World Congresses of Gastroenterology. Working party reports. Melbourne, Blackwell, 1990, pp 36–45
Rauws EAJ, Tytgat G: Cure of duodenal ulcer associated with eradication ofHelicobacter pylori. Lancet i:1233–1235, 1990
Borody TJ, Cole P, Noonan S, Morgan A, Ossip G, Maysey J, Brandl S: Long termCampylobacter pylori recurrence post eradication. Gastroenterology 94:43, 1988 (abstract)
Kurata JH: Ulcer epidemiology: An overview and proposed research framework. Gastroenterology 96:569–580, 1989
Martin DF, Montgomery JE, Dobek AS, Patrissi GA, Peura DA:Campylobacter pylori, NSAIDs and smoking: Risk factors for peptic ulcer disease. Am J Gastroenterol 84:1268–1272, 1989
George L, Hyland L, Morgan A, Cole P, Andrews P, Brandl S, Borody T: Smoking does not contribute to duodenal ulcer relapse afterHelicobacter pylori eradication. Gastroenterology 98:A48, 1990
Graham DY:Helicobacter pylori: Its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 6:105–115, 1991
Coggon D, Lambert P, Langman MJS: 20 years of hospital admisstions for peptic ulcer in England and Wales. Lancet 1:1302–1304, 1981
Susser M: Civilization and peptic ulcer. Lancet 1:115–119, 1962
Goodwin CS: Duodenal ulcer,Campylobacter pylori, and the “leaking roof” concept. Lancet 2:1467–1469, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mégraud, F., Lamouliatte, H. Helicobacter pylori and duodenal ulcer. Digest Dis Sci 37, 769–772 (1992). https://doi.org/10.1007/BF01296437
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01296437